RT Journal Article
SR Electronic
T1 A throughput serological Western blot system using whole virus lysate for the concomitant detection of antibodies against SARS-CoV-2 and human endemic Coronaviridae
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.31.20165019
DO 10.1101/2020.07.31.20165019
A1 Fink, Simon
A1 Ruoff, Felix
A1 Stahl, Aaron
A1 Becker, Matthias
A1 Kaiser, Philipp
A1 Traenkle, Bjoern
A1 Junker, Daniel
A1 Weise, Frank
A1 Ruetalo, Natalia
A1 Hörber, Sebastian
A1 Peter, Andreas
A1 Nelde, Annika
A1 Walz, Juliane
A1 Krause, Gérard
A1 Schenke-Layland, Katja
A1 Joos, Thomas
A1 Rothbauer, Ulrich
A1 Schneiderhan-Marra, Nicole
A1 Schindler, Michael
A1 Templin, Markus F.
YR 2020
UL http://medrxiv.org/content/early/2020/08/04/2020.07.31.20165019.abstract
AB Background Seroreactivity against human endemic coronaviruses has been linked to disease severity after SARS-CoV-2 infection. Assays that are capable of concomitantly detecting antibodies against endemic coronaviridae such as OC43, 229E, NL63, and SARS-CoV-2 may help to elucidate this question. We set up a platform for serum-screening and developed a bead-based Western blot system, namely DigiWest, capable of running hundreds of assays using microgram amounts of protein prepared directly from different viruses.Methods The parallelized and miniaturised DigiWest assay was adapted for detecting antibodies using whole protein extract prepared from isolated SARS-CoV-2 virus particles. After characterisation and optimization of the newly established test, whole virus lysates of OC43, 229E, and NL63 were integrated into the system.Results The DigiWest-based immunoassay system for detection of SARS-CoV-2 specific antibodies shows a sensitivity of 87.2 % and diagnostic specificity of 100 %. Concordance analysis with the SARS-CoV-2 immunoassays available by Roche, Siemens, and Euroimmun indicates a comparable assay performance (Cohen’s Kappa ranging from 0.8799-0.9429). In the multiplexed assay, antibodies against the endemic coronaviruses OC43, 229E, and NL63 were detected, displaying a high incidence of seroreactivity against these coronaviruses.Conclusion The DigiWest-based immunoassay, which uses authentic antigens from isolated virus particles, is capable of detecting individual serum responses against SARS-CoV-2 with high specificity and sensitivity in one multiplexed assay. It shows high concordance with other commercially available serologic assays. The DigiWest approach enables a concomitant detection of antibodies against different endemic coronaviruses and will help to elucidate the role of these possibly cross-reactive antibodies.Competing Interest StatementM.F.T. have filed patent PCT/EP2012/062403 that covers parts of the Digiwest method. The remaining authors declare no competing financial interests.Funding StatementThis work has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 101003480 - CORESMA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:(179/2020/BO2) (495/2018/BO2)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSupplementary material is available online.